Here is my weekly selection of #anticancer #therapy and #metabolic #reprogramming. Enjoy!
biomed.news/bims-meract/...
๐ @biomednews.bsky.social
@andreamorandi.bsky.social
Associate Professor of Biochemistry and PI of the Tumour Biochemistry Lab @UNIFI | Head of the Breast Unit Translational Lab @AOUC https://www.sbsc.unifi.it/vp-326-gruppo-morandi.html https://www.ncbi.nlm.nih.gov/myncbi/1JM7xFr2A8y56/bibliography/public
Here is my weekly selection of #anticancer #therapy and #metabolic #reprogramming. Enjoy!
biomed.news/bims-meract/...
๐ @biomednews.bsky.social
Here is my weekly selection of #anticancer #therapy and #metabolic #reprogramming! ๐ @biomednews.bsky.social
biomed.news/bims-meract/...
๐ฃ Itโs been a productive few days for our group!
๐กOur new paper in ๐๐ฆ๐ญ๐ญ ๐๐ฆ๐ข๐ต๐ฉ & ๐๐ช๐ด๐ฆ๐ข๐ด๐ฆ shows that lead nitrate drives NRF2-dependent metabolic reprogramming and proliferation in hepatocytes.
With Universitร di Cagliari & Universitร di Torino, funded by MUR#PRIN2022.
๐ www.nature.com/articles/s41...
Here is my weekly selection of #anticancer #therapy and #metabolic #reprogramming! Super interesting papers this issue (including our last study๐๐คฉ๐) Enjoy! ๐ @biomednews.bsky.social biomed.news/bims-meract/...
09.11.2025 08:23 โ ๐ 8 ๐ 5 ๐ฌ 0 ๐ 0๐
08.11.2025 20:09 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0๐
08.11.2025 20:09 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0๐จ Our new paper is now out in ๐๐ข๐ฏ๐ค๐ฆ๐ณ ๐๐ฆ๐ด๐ฆ๐ข๐ณ๐ค๐ฉ!
ESR1 mutations in ERโบ breast cancer rewire lipid metabolism, creating a ferroptosis vulnerability ๐ฌ
ACSL4 is a key biomarker & combo with SERDs offers a new strategy.
๐ Congrats to the whole #TBTlab & collaborators!
aacrjournals.org/cancerres/ar...
Here is my weekly selection of #anticancer #therapy and #metabolic #reprogramming! Many interesting paper today ๐คฉ Enjoy and feedback! ๐ @biomednews.bsky.social biomed.news/bims-meract/...
02.11.2025 16:24 โ ๐ 6 ๐ 2 ๐ฌ 0 ๐ 0Thanks Federica and congratulations once again! ๐ฅณ
30.10.2025 20:03 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0Here a selection of last week studies on #anticancer #therapy and #metabolic #reprogramming. Big thanks @biomednews.bsky.social for presorting them.
V good studies in this issue, have a look
biomed.news/bims-meract/...
Busy weekdays and busy weekends. A bit late but please find two selection lists of #anticancer #therapy and #metanolism. Hope you find some useful studies. Thanks @biomednews.bsky.social
(1) biomed.news/bims-meract/...
(2) biomed.news/bims-meract/...
Hereโs my weekly selection of #anticancer #therapy and #metabolic #reprogramming. From now on, Iโll focus on papers in journals with solid peer-review โ a personal choice and point of view. ๐ @biomednews.bsky.social
biomed.news/bims-meract/...
Here is my weekly selection on #anticancer #therapy and #metabolic #reprogramming. Hope you enjoy! biomed.news/2025-09-14 ๐ @biomednews.bsky.social
14.09.2025 13:43 โ ๐ 5 ๐ 3 ๐ฌ 0 ๐ 0Here is my weekly selection of #anticancer #therapy and #metabolism #reprogramming. Enjoy! biomed.news/bims-meract/...
09.09.2025 07:27 โ ๐ 2 ๐ 1 ๐ฌ 0 ๐ 0Another week has gone ๐จ! Here is my weekly selection for #anticancer #metabolic #reprogramming! Enjoy
03.08.2025 19:22 โ ๐ 4 ๐ 2 ๐ฌ 0 ๐ 0Good Sunday all. A beautiful selection of papers in #cancermetabolism and #mitochondrialbiology is ready for you here: biomed.news/bims-camemi/... @biomednews.bsky.social #keepreading
"If your eyes are blinded with your worries, you cannot see the beauty of the sunset." - Jiddu Krishnamurti
Here is my weekly selection of #anticancer #therapy and #metabolic #reprogramming. ๐ @biomednews.bsky.social Enjoy and share ๐ biomed.news/bims-meract/...
27.07.2025 11:45 โ ๐ 8 ๐ 6 ๐ฌ 0 ๐ 0Here is my weekly selection on #cancer #metabolism and #therapy #response and #resistance, enjoy! biomed.news/bims-meract/...
15.07.2025 17:09 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0New weekly selection out! #anticancer #therapy #resistance #metabolism
Enjoy! @biomednews.bsky.social
biomed.news/bims-meract/...
You might be interested to know about an upcoming EACR-sponsored meeting organised by the Italian Cancer Society, an affiliated National Society of the EACR.
65th Annual Meeting of the Italian Cancer Society
๐
03-05 Dec 2025
๐ Turin, Italy
sic2025.cancerologia.it
Here is my weekly selection for #anticancer #tgerapy and #metabolic #reprograming. Enjoy!
biomed.news/bims-meract/...
๐ @biomednews.bsky.social
๐ฃNew study w/ Dr. Longoโs team @UNITO shows MRI-CEST tumor pH imaging can differentiate metastatic from non-metastatic breast tumors via acidosis + spatial heterogeneity ๐งช A big step toward metabolic markers of malignancy!
breast-cancer-research.biomedcentral.com/articles/10....
Good morning and good weekend everyone! Hereโs my weekly selection of #anticancer #therapy and #metabolic #reprogramming, enjoy!
biomed.news/bims-meract/...
Great to take part in the Early Career Researcher Speed Networking! Enjoyed sharing my experience as junior PI and future research plans and the hurdles ahead. #ECR #ResearchLife #EACR2025
18.06.2025 16:34 โ ๐ 7 ๐ 1 ๐ฌ 0 ๐ 0Great atmosphere at the symposium: interactive, engaging, and a fantastic space for young researchers to join the discussion. Truly a pleasure to be part of it. Hope to see this session back in future editions! @helloeacr.bsky.social #EACR2025
16.06.2025 10:39 โ ๐ 6 ๐ 1 ๐ฌ 0 ๐ 0Weekly selection of #anticancer #therapy and #metabolic #reprogramming. Enjoy.
biomed.news/bims-meract/... bims-meract 2025-06-15 papers
๐ @biomednews.bsky.social
We're excited to introduce you to our Congress Correspondents who will be sharing real-time highlights from #EACR2025
Follow them ahead of the Congress starting on 16 June:
๐ @peioazcoaga.bsky.social
๐ @simofu.bsky.social
๐ @vrscience.bsky.social
๐ @luisa86ferreira.bsky.social
๐ @isaqg.bsky.social
Here is my weekly selection of #anticancer #therapy and #metabolic #reprogramming!
Enjoy!
biomed.news/bims-meract/...
Good Sunday everybody! Here is my weekly selection of #anticancer #therapy and #metabolism. Enjoy! biomed.news/bims-meract/...
25.05.2025 05:54 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0.๐งฌWe looked for a CD44:SLC1A2 fusion in breast cancer. The data said no. Instead of shelving it, we published.
๐ข Now out in @SpringerNature MCB: link.springer.com/article/10.1...
Negative results matter. Transparency matters. Proud of this one ๐ฅณ! #OpenScience